Background: Post-infectious autoimmunity and immune deficiency have been implicated in the pathogenesis of Tourette syndrome (TS). We asked here whether B cell immunity of patients with TS differs from healthy subjects. Methods: In two independent cross-sectional samples, we compared serum levels of IgG1, IgG2, IgG3, IgG4, IgM, IgA, and IgE in 21 patients with TS from Yale University (17 males, 4 females, 8-16 years) versus 21 healthy controls (13 males, 8 females, 7-17 years); and in 53 patients with TS from Groningen University (45 males, 8 females, 6-18 years) versus 53 healthy controls (22 males, 31 females, 6-18 years), respectively. We also investigated correlations between Ig concentrations and symptom severity. In 13 additional patients (9 males, 4 females, age range 9-14), we established Ig profiles at time points before, during, and after symptom exacerbations. Results: IgG3 levels were significantly lower in Yale patients compared to healthy children (medians 0.28 versus 0.49 mg/ml, p = .04), while levels of IgG2, IgG4, and IgM in patients were lower at trend-level significance (p 6 .10). Decreased IgG3 (medians 0.45 versus 0.52 mg/ml; p = .05) and IgM (medians 0.30 versus 0.38 mg/ml; p = .04) levels were replicated in the Groningen patients. Ig levels did not correlate with symptom severity. There was a trend-level elevation of IgG1 during symptom exacerbations (p = .09). Conclusion: These pilot data indicate that at least some patients with TS have decreased serum IgG3, and possibly also IgM levels, though only few subjects had fully expressed Ig immunodeficiency. Whether these changes are related to TS pathogenesis needs to be investigated.
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Introduction
Tourette syndrome (TS) is a chronic neuropsychiatric disorder characterized by the presence of involuntary, rapid, recurrent, non-rhythmic movements, and/or vocalizations, often accompanied by obsessions and/or compulsions. The onset of symptoms occurs mostly between 5 and 7 years of age, symptoms typically wax and wane over time, and the disorder is often outgrown by young adulthood, except in a minority of cases (Leckman, 2002; Lombroso and Scahill, 2008) .
Strong evidence indicates that the disorder is hereditary, but the exact mechanisms involved in the genetic transmission are not resolved (Hoekstra et al., 2004 ). It appears that TS is genetically heterogeneous and that environmental factors may influence the onset, course, and severity of symptoms. Among multiple environmental factors, infections with group A beta hemolytic streptococcus (GABHS) have been proposed to play a key role in the pathogenesis of TS in at least some patients. This has received significant attention after a wave of infections with GABHS in Rhode Island was followed by increased frequency of tic disorders in pediatric practice (Kiessling et al., 1993) . A subgroup of patients with TS with a medical history of GABHS infection prior to the onset of TS symptoms was designated as PANDAS (pediatric autoimmune neuropsychiatric disorders associated with streptococcal infections) (Swedo et al., 1998) . In addition, other infections were implicated in TS by studies demonstrating that common cold preceded TS symptom exacerbations (Hoekstra et al., 2005) and that antibodies against mycoplasma pneumoniae are elevated in patients with TS (Muller et al., 2004) , and by case reports suggesting relations of TS with Lyme disease (Riedel et al., 1998) 
